Mode of Action, Clinical Profile and Significance of Beta-Blockers in Antiglaucoma Therapy

被引：3
|
作者：
Schlote, T. [1 ]
机构：
[1] Tagesklin Ambimed, CH-4057 Basel, Switzerland
来源：
KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE | 2013年 / 230卷 / 02期
关键词：
glaucoma; pharmacology; biochemistry; DIURNAL INTRAOCULAR-PRESSURE; TIMOLOL MALEATE; UNFIXED COMBINATION; FIXED COMBINATION; GLAUCOMA PATIENTS; EFFICACY; TOLERABILITY; METAANALYSIS; EXFOLIATION; SAFETY;
D O I：
10.1055/s-0032-1327784
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
Beta-blockers are among the most important groups of drugs for glaucoma therapy. The advantages of beta-blockers are a good efficacy in primary and secondary types of glaucoma, different dosages, clinical experiences over decades, easy use in combination with all other glaucoma drugs, and low costs. Timolol is the most frequently used drug in fixed glaucoma medications. In comparison with other glaucoma drugs, beta-blockers have the most severe systemic side effects and may interact with other systemic medication.
引用
收藏
页码：120 / 126
页数：7
相关论文
共 50 条
  • [1] Clinical and inhaled drug profile of COPD patients with indication for beta-blockers who are on beta-blockers
    Malo de Molina, Rosa
    Fuster, Antonia
    Jorge Marcos, Pedro
    Marquez, Eduardo
    Calero, Carmen
    Tirado, Gema
    Alcazar, Bernardino
    Calle, Myriam
    Puente, Luis
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [2] MODE OF ACTION OF BETA-BLOCKERS IN ANGINA-PECTORIS
    ABLAD, B
    EK, L
    JOHNSSON, G
    SCOTTISH MEDICAL JOURNAL, 1977, 22 (01) : 52 - 63
  • [3] THE MODE OF ACTION OF BETA-BLOCKERS ON THE STANDING POTENTIAL OF THE EYE
    MISSOTTEN, L
    VANTORNOUT, I
    AVOUX, G
    VANWIJNENDAELE, J
    OPHTHALMIC RESEARCH, 1981, 13 (05) : 258 - 258
  • [4] NOVEL SOFT BETA-BLOCKERS AS POTENTIAL SAFE ANTIGLAUCOMA AGENTS
    BODOR, N
    ELKOUSSI, A
    CURRENT EYE RESEARCH, 1988, 7 (04) : 369 - 374
  • [5] DURATION OF ACTION OF BETA-BLOCKERS
    JOHANSSON, SR
    MCCALL, M
    WILHELMSSON, C
    VEDIN, JA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (05) : 593 - 601
  • [6] ANTIHYPERTENSIVE ACTION OF BETA-BLOCKERS
    TAKEDA, K
    SAKURAI, H
    IMAI, S
    FOLIA PHARMACOLOGICA JAPONICA, 1974, 70 (04) : P142 - P143
  • [7] ANTIHYPERTENSIVE ACTION OF BETA-BLOCKERS
    TAKEDA, K
    SAKURAI, H
    IMAI, S
    JAPANESE JOURNAL OF PHARMACOLOGY, 1974, 24 : 73 - 73
  • [8] POSSIBLE SIGNIFICANCE OF THE PHARMACOLOGICAL DIFFERENTIATION OF BETA-BLOCKERS FOR THERAPY OF HYPERTENSION
    LEENEN, FHH
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 7 : S173 - S184
  • [9] LIPOPHILIA FROM BETA-BLOCKERS - CLINICAL-PHARMACOLOGICAL SIGNIFICANCE
    ARENDT, RM
    OCHS, HR
    ZEITSCHRIFT FUR KARDIOLOGIE, 1986, 75 : 37 - 37
  • [10] BETA-BLOCKERS - DRUG-INTERACTIONS OF CLINICAL-SIGNIFICANCE
    BLAUFARB, I
    PFEIFER, TM
    FRISHMAN, WH
    DRUG SAFETY, 1995, 13 (06) : 359 - 370
12345